ARK Innovation or Health Care — which is the better buy?

The honest answer comes from running the same workflow on both: quality score, valuation ceiling versus today's price, and which thesis breaks worry you more. The snapshot table below gives the current dated state of each.

How are ARKK and XLV different?

ARK Innovation trades on US (ETF); Health Care trades on US (ETF). Market, currency, liquidity, and disclosure regimes differ — the workflow stays identical, so the comparison is fair.

Comparison · Updated 2026-08-29

ARK Innovation vs Health Care

Which is stronger right now? The dated snapshot below answers it with quality, valuation ceiling, risk, and timing — side by side, then the full decision brief.

By the Balance Labs Research Desk · Reviewed by the editorial review board · 2026-08-29

Two tickers, one decision framework. Instead of vibes, put both names through the same quality → valuation → thesis-breaks → timing process and let the weaker story drop.

Key facts — quick answer

ARKK = ARK Innovation (US) · XLV = Health Care (US).
Snapshot 2026-08-29: ARKK $85.78 · signal LONG · ret +27.0% ‖ XLV $173.54 · signal LONG · ret +16.5%.
The one with the wider gap between price and its valuation ceiling — at equal quality — usually wins the slot.

Snapshot comparison (2026-08-29)

	ARKK	XLV
Company	ARK Innovation	Health Care
Market	🇺🇸 US	🇺🇸 US
Sector	ETF	ETF
Price	$85.78	$173.54
Signal	LONG · +10.7%	LONG · +15.8%
Total return	+27.0%	+16.5%

Decide it with the calculator

Run both names through the free intrinsic value calculator — the one with the wider gap between price and ceiling on equal quality usually wins the slot.

See the full decision brief

ARKK decision brief XLV decision brief

Deeper comparison — ARK Innovation (ARKK) vs Health Care (XLV)

Beyond the snapshot above, the real comparison comes from running the same workflow on both companies: score quality, set the valuation ceiling, and write the break conditions for each. The framework stays identical; only the data changes.

Dimension	ARKK	XLV
Market	🇺🇸 US	🇺🇸 US
Sector	ETF	ETF
STM signal	LONG	LONG
uPnL	+10.7%	+15.8%
Total return	+27.0%	+16.5%

Use this table as a starting point, not an answer. The decision comes from running the full workflow on both companies — ARKK brief · XLV brief — and comparing the outputs side by side.

★

Get more Balance Labs in your Google results

Add balancelabs.app as a Preferred Source on Google.

Cite this page

Balance Labs Research Desk. "ARK Innovation vs Health Care" https://balancelabs.app/stocks/compare/arkk-vs-xlv. Data snapshot: 2026-08-29. CC BY 4.0 with attribution.

ASK STOCK CHAT

Ask anything about ARKK

Same AI engine as this decision brief — grounded in live tool reports.

Should I buy ARKK at these levels?What would break the ARKK thesis?ARKK vs XLV — which has more room?

30 free credits monthly · no card required · research support, not advice

← All guides · Home · Data snapshot 2026-08-29 · Not investment advice.